Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 764

1.

Multicentre reference values for cardiac magnetic resonance imaging derived ventricular size and function for children aged 0-18 years.

van der Ven JPG, Sadighy Z, Valsangiacomo Buechel ER, Sarikouch S, Robbers-Visser D, Kellenberger CJ, Kaiser T, Beerbaum P, Boersma E, Helbing WA.

Eur Heart J Cardiovasc Imaging. 2019 Jul 5. pii: jez164. doi: 10.1093/ehjci/jez164. [Epub ahead of print]

PMID:
31280290
2.

Impact of telemedicine interventions on mortality in patients with acute myocardial infarction: a systematic review and meta-analysis.

Marcolino MS, Maia LM, Oliveira JAQ, Melo LDR, Pereira BLD, Andrade-Junior DF, Boersma E, Ribeiro AL.

Heart. 2019 Jun 28. pii: heartjnl-2018-314539. doi: 10.1136/heartjnl-2018-314539. [Epub ahead of print]

PMID:
31253696
3.

Repeated Echocardiograms Do Not Provide Incremental Prognostic Value to Single Echocardiographic Assessment in Minimally Symptomatic Patients with Chronic Heart Failure: Results of the Bio-SHiFT Study.

van den Berg VJ, Strachinaru M, Akkerhuis KM, Baart S, Brankovic M, Constantinescu AA, Cornel JH, Manintveld OC, Umans VAWM, Rizopoulos D, Geleijnse ML, Boersma E, van Dalen BM, Kardys I.

J Am Soc Echocardiogr. 2019 Jun 20. pii: S0894-7317(19)30641-8. doi: 10.1016/j.echo.2019.04.419. [Epub ahead of print]

PMID:
31230778
4.

Effect of Antiplatelet Drugs on D-Dimer Levels: A Systematic Review and Meta-analysis.

Morelli F, Schol-Gelok S, Arends LR, Boersma E, Kruip MJHA, Versmissen J, van Gelder T.

J Cardiovasc Pharmacol. 2019 Jun;73(6):343-351. doi: 10.1097/FJC.0000000000000670.

PMID:
31162242
5.

Understanding of interaction (subgroup) analysis in clinical trials.

Brankovic M, Kardys I, Steyerberg EW, Lemeshow S, Markovic M, Rizopoulos D, Boersma E.

Eur J Clin Invest. 2019 May 28:e13145. doi: 10.1111/eci.13145. [Epub ahead of print] Review.

PMID:
31135965
6.

A revised systematic review and meta-analysis on the effect of statins on D-dimer levels.

Schol-Gelok S, Morelli F, Arends LR, Boersma E, Kruip MJHA, Versmissen J, van Gelder T.

Eur J Clin Invest. 2019 May 21:e13130. doi: 10.1111/eci.13130. [Epub ahead of print] Review.

PMID:
31112290
7.

Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission.

Vroegindewey MM, van den Berg VJ, Bouwens E, Akkerhuis KM, Oemrawsingh RM, Asselbergs FW, Lenderink T, van der Harst P, Ronner E, Umans VAWM, Kardys I, Boersma E.

Am Heart J. 2019 Apr 6. pii: S0002-8703(19)30052-3. doi: 10.1016/j.ahj.2019.02.016. [Epub ahead of print]

PMID:
31053235
8.

Coronary artery calcification in middle-aged women with premature ovarian insufficiency.

Gunning MN, Meun C, van Rijn BB, Maas AHEM, Benschop L, Franx A, Boersma E, Budde RPJ, Appelman Y, Lambalk CB, Eijkemans MJC, Velthuis BK, Laven JSE, Fauser BCJM; CREW-consortium.

Clin Endocrinol (Oxf). 2019 Aug;91(2):314-322. doi: 10.1111/cen.14003. Epub 2019 May 23.

PMID:
31049984
9.

Temporal Pattern of Growth Differentiation Factor-15 Protein After Acute Coronary Syndrome (From the BIOMArCS Study).

Buljubasic N, Vroegindewey MM, Oemrawsingh RM, Asselbergs FW, Cramer E, Liem A, van der Harst P, Maas A, Ronner E, Schotborgh C, Wardeh AJ, Akkerhuis KM, Boersma E; BIOMArCS investigators.

Am J Cardiol. 2019 Jul 1;124(1):8-13. doi: 10.1016/j.amjcard.2019.03.049. Epub 2019 Apr 18.

PMID:
31047655
10.

Sex differences in characteristics and outcome in acute coronary syndrome patients in the Netherlands.

Ten Haaf ME, Bax M, Ten Berg JM, Brouwer J, Van't Hof AW, van der Schaaf RJ, Stella PR, Tjon Joe Gin RM, Tonino PA, de Vries AG, Zijlstra F, Boersma E, Appelman Y.

Neth Heart J. 2019 May;27(5):263-271. doi: 10.1007/s12471-019-1271-0.

11.

Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC).

Roos-Hesselink J, Baris L, Johnson M, De Backer J, Otto C, Marelli A, Jondeau G, Budts W, Grewal J, Sliwa K, Parsonage W, Maggioni AP, van Hagen I, Vahanian A, Tavazzi L, Elkayam U, Boersma E, Hall R.

Eur Heart J. 2019 Mar 25. pii: ehz136. doi: 10.1093/eurheartj/ehz136. [Epub ahead of print]

PMID:
30907409
12.

Subsequent Event Risk in Individuals With Established Coronary Heart Disease.

Patel RS, Tragante V, Schmidt AF, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Allayee H, Almgren P, Alver M, Baranova EV, Behloui H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dubé MP, Dufresne L, Eriksson N, Foco L, Scholz M, Gijsberts CM, Glinge C, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kotti S, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, Van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Al Ali L, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Engstrøm T, Fitzpatrick N, Fox K, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton-Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Boersma EH, Bogaty P, Bots ML, Brenner H, Brugts JJ, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, Danchin N, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Grobbee DE, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Jabbari R, Johnson JA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Niemcunowicz-Janica A, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Siegbahn A, Simon T, Sinisalo J, Smith JG, Spertus JA, Stender S, Stewart AFR, Szczeklik W, Szpakowicz A, Tardif JC, Ten Berg JM, Tfelt-Hansen J, Thanassoulis G, Thiery J, Torp-Pedersen C, van der Graaf Y, Visseren FLJ, Waltenberger J, Weeke PE, Van der Harst P, Lang CC, Sattar N, Cameron VA, Anderson JL, Brophy JM, Pare G, Horne BD, März W, Wallentin L, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002470. doi: 10.1161/CIRCGEN.119.002470. Epub 2019 Mar 21.

PMID:
30896328
13.

The Influence of Multidirectional Shear Stress on Plaque Progression and Composition Changes in Human Coronary Arteries.

Kok AM, Molony DS, Timmins LH, Ko YA, Boersma E, Eshtehardi P, Wentzel JJ, Samady H.

EuroIntervention. 2019 Mar 12. pii: EIJ-D-18-00529. doi: 10.4244/EIJ-D-18-00529. [Epub ahead of print]

15.

Reference values for two-dimensional myocardial strain echocardiography of the left ventricle in healthy children.

Koopman LP, Rebel B, Gnanam D, Menting ME, Helbing WA, Boersma E.

Cardiol Young. 2019 Mar;29(3):325-337. doi: 10.1017/S1047951118002378. Epub 2019 Feb 19.

PMID:
30777588
16.

Expanded carrier screening for autosomal recessive conditions in health care: Arguments for a couple-based approach and examination of couples' views.

Plantinga M, Birnie E, Schuurmans J, Buitenhuis AH, Boersma E, Lucassen AM, Verkerk MA, van Langen IM, Ranchor AV.

Prenat Diagn. 2019 Apr;39(5):369-378. doi: 10.1002/pd.5437. Epub 2019 Feb 28.

17.

New Generation mechanical circulatory support during high-risk PCI: a cross sectional analysis.

Ameloot K, B Bastos M, Daemen J, Schreuder J, Boersma E, Zijlstra F, Van Mieghem NM.

EuroIntervention. 2019 Feb 12. pii: EIJ-D-18-01126. doi: 10.4244/EIJ-D-18-01126. [Epub ahead of print]

18.

Explanation of Postprocedural Fractional Flow Reserve Below 0.85.

van Zandvoort LJC, Masdjedi K, Witberg K, Ligthart J, Tovar Forero MN, Diletti R, Lemmert ME, Wilschut J, de Jaegere PPT, Boersma E, Zijlstra F, Van Mieghem NM, Daemen J.

Circ Cardiovasc Interv. 2019 Feb;12(2):e007030. doi: 10.1161/CIRCINTERVENTIONS.118.007030.

PMID:
30732469
19.

Risk Factors for Pulmonary Hypertension in Adults After Atrial Septal Defect Closure.

Zwijnenburg RD, Baggen VJM, Witsenburg M, Boersma E, Roos-Hesselink JW, van den Bosch AE.

Am J Cardiol. 2019 Apr 15;123(8):1336-1342. doi: 10.1016/j.amjcard.2019.01.011. Epub 2019 Jan 24.

PMID:
30709596
20.

Joint models for longitudinal and time-to-event data in a case-cohort design.

Baart SJ, Boersma E, Rizopoulos D.

Stat Med. 2019 May 30;38(12):2269-2281. doi: 10.1002/sim.8113. Epub 2019 Jan 31.

21.

Prognostic value of soluble ST2 in adults with congenital heart disease.

Geenen LW, Baggen VJM, van den Bosch AE, Eindhoven JA, Cuypers JAAE, Witsenburg M, Boersma E, Roos-Hesselink JW.

Heart. 2019 Jul;105(13):999-1006. doi: 10.1136/heartjnl-2018-314168. Epub 2019 Jan 30.

22.

Response: Serial blood biomarker measurements for elucidation of the pathophysiology of heart failure.

van Boven N, Akkerhuis KM, Umans V, Boersma E, Kardys I.

Int J Cardiol. 2019 Mar 1;278:266. doi: 10.1016/j.ijcard.2018.11.128. No abstract available.

PMID:
30683330
23.

Cardiovascular risk prediction models for women in the general population: A systematic review.

Baart SJ, Dam V, Scheres LJJ, Damen JAAG, Spijker R, Schuit E, Debray TPA, Fauser BCJM, Boersma E, Moons KGM, van der Schouw YT; CREW consortium.

PLoS One. 2019 Jan 8;14(1):e0210329. doi: 10.1371/journal.pone.0210329. eCollection 2019.

24.

Serial high-sensitivity cardiac troponin T measurements to rule out acute myocardial infarction and a single high baseline measurement for swift rule-in: A systematic review and meta-analysis.

Arslan M, Dedic A, Boersma E, Dubois EA.

Eur Heart J Acute Cardiovasc Care. 2019 Jan 8:2048872618819421. doi: 10.1177/2048872618819421. [Epub ahead of print]

PMID:
30618277
25.

Design and rationale of haemodynamic guidance with CardioMEMS in patients with a left ventricular assist device: the HEMO-VAD pilot study.

Veenis JF, Manintveld OC, Constantinescu AA, Caliskan K, Birim O, Bekkers JA, van Mieghem NM, den Uil CA, Boersma E, Lenzen MJ, Zijlstra F, Abraham WT, Adamson PB, Brugts JJ.

ESC Heart Fail. 2019 Feb;6(1):194-201. doi: 10.1002/ehf2.12392. Epub 2019 Jan 7.

26.

High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome.

Oemrawsingh RM, Akkerhuis KM, de Mulder M, Umans VA, Kietselaer B, Schotborgh C, Ronner E, Lenderink T, Liem A, Haitsma D, van der Harst P, Asselbergs FW, Maas A, Oude Ophuis AJ, Ilmer B, Dijkgraaf R, de Winter RJ, Kie The SH, Wardeh AJ, Hermans W, Cramer E, van Schaik RH, Hoefer IE, Doevendans PA, Simoons ML, Boersma E; BIOMArCS Investigators.

Circulation. 2019 Jan 2;139(1):134-136. doi: 10.1161/CIRCULATIONAHA.118.036349. No abstract available.

PMID:
30592652
27.

Adverse Childhood Experiences Are Not Associated With Patient-reported Outcome Measures in Patients With Musculoskeletal Illness.

Ottenhoff JSE, Kortlever JTP, Boersma EZ, Laverty DC, Ring D, Driscoll MD.

Clin Orthop Relat Res. 2019 Jan;477(1):219-228. doi: 10.1097/CORR.0000000000000519.

PMID:
30586342
28.

The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach.

Geenen LW, Baggen VJM, Koudstaal T, Boomars KA, Eindhoven JA, Boersma E, Roos-Hesselink JW, van den Bosch AE.

Am Heart J. 2019 Feb;208:91-99. doi: 10.1016/j.ahj.2018.11.001. Epub 2018 Nov 24.

PMID:
30580131
29.

Comparison of the Diagnostic Performance of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve in Patients With Versus Without Diabetes Mellitus (from the MACHINE Consortium).

Nous FMA, Coenen A, Boersma E, Kim YH, Kruk MBP, Tesche C, de Geer J, Yang DH, Kepka C, Schoepf UJ, Persson A, Kurata A, Budde RPJ, Nieman K.

Am J Cardiol. 2019 Feb 15;123(4):537-543. doi: 10.1016/j.amjcard.2018.11.024. Epub 2018 Nov 24.

PMID:
30553510
30.

Five Year Safety and Performance Data of a Novel Third Generation Novolimus-eluting Bio-resorbable Scaffold in a Single De-novo Lesion.

Verheye S, Costa RA, Schofer J, Ormiston JA, Maeng M, Dudek D, Skurk C, Botelho RV, Costa JR, Chamié D, Abizaid AS, Boersma E, Abizaid AA.

EuroIntervention. 2018 Dec 11. pii: EIJ-D-18-00292. doi: 10.4244/EIJ-D-18-00292. [Epub ahead of print] No abstract available.

31.

The temporal pattern of immune and inflammatory proteins prior to a recurrent coronary event in post-acute coronary syndrome patients.

Vroegindewey MM, Oemrawsingh RM, Kardys I, Asselbergs FW, van der Harst P, Oude Ophuis AJ, Etienne Cramer G, Maas A, Hong Kie The S, Wardeh AJ, Mouthaan H, Boersma E, Akkerhuis KM.

Biomarkers. 2019 Mar;24(2):199-205. doi: 10.1080/1354750X.2018.1539768. Epub 2018 Dec 4.

PMID:
30514120
32.

Adiponectin in Relation to Coronary Plaque Characteristics on Radiofrequency Intravascular Ultrasound and Cardiovascular Outcome.

Marino BCA, Buljubasic N, Akkerhuis M, Cheng JM, Garcia-Garcia HM, Regar E, Geuns RV, Serruys PW, Boersma E, Kardys I.

Arq Bras Cardiol. 2018 Sep;111(3):345-353. doi: 10.5935/abc.20180172. English, Portuguese.

33.

Dataset on blood biomarkers and GRACE score measured at admission for myocardial infarction in a large secondary hospital.

van den Berg VJ, van Toorenburg M, Drexhage O, Boersma E, Kardys I, Umans VAWM.

Data Brief. 2018 Oct 3;21:371-376. doi: 10.1016/j.dib.2018.09.126. eCollection 2018 Dec.

34.

e-Transmission of ECGs for expert consultation results in improved triage and treatment of patients with acute ischaemic chest pain by ambulance paramedics.

Anroedh SS, Kardys I, Akkerhuis KM, Biekart M, van der Hulst B, Deddens GJ, Smits P, Gardien M, Dubois E, Zijlstra F, Boersma E.

Neth Heart J. 2018 Nov;26(11):562-571. doi: 10.1007/s12471-018-1187-0.

35.

Ventricular Response to Dobutamine Stress CMR Is a Predictor for Outcome in Fontan Patients.

van den Bosch E, Bossers SSM, Robbers-Visser D, Boersma E, Roos-Hesselink JW, Breur HMPJ, Blom NA, Kroft LJM, Snoeren MM, Kapusta L, Helbing WA.

JACC Cardiovasc Imaging. 2019 Feb;12(2):368-370. doi: 10.1016/j.jcmg.2018.07.025. Epub 2018 Oct 17. No abstract available.

PMID:
30343077
36.

Response to Letter to the Editor: "Cardiometabolic Biomarkers and Their Temporal Patterns Predict Poor Outcome in Chronic Heart Failure (Bio-SHiFT Study)".

Brankovic M, Akkerhuis KM, Umans V, Boersma E, Kardys I.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):736-737. doi: 10.1210/jc.2018-02149. No abstract available.

PMID:
30339257
37.

Prognostic Value of Intravascular Ultrasound in Patients With Coronary Artery Disease.

Schuurman AS, Vroegindewey MM, Kardys I, Oemrawsingh RM, Garcia-Garcia HM, van Geuns RJ, Regar E, Van Mieghem NM, Ligthart J, Serruys PW, Boersma E, Akkerhuis KM.

J Am Coll Cardiol. 2018 Oct 23;72(17):2003-2011. doi: 10.1016/j.jacc.2018.08.2140.

PMID:
30336823
38.

Associations of 26 Circulating Inflammatory and Renal Biomarkers with Near-Infrared Spectroscopy and Long-term Cardiovascular Outcome in Patients Undergoing Coronary Angiography (ATHEROREMO-NIRS Substudy).

Anroedh SS, Akkerhuis KM, Oemrawsingh RM, Garcia-Garcia HM, Brankovic M, Regar E, van Geuns RJ, Serruys PW, Daemen J, van Mieghem NM, Boersma E, Kardys I.

Curr Atheroscler Rep. 2018 Sep 14;20(10):52. doi: 10.1007/s11883-018-0752-8. Review.

39.

Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy.

Dam V, Onland-Moret NC, Verschuren WMM, Boer JMA, Benschop L, Franx A, Moons KGM, Boersma E, van der Schouw YT; CREW-consortium.

Heart. 2018 Sep 12. pii: heartjnl-2018-313439. doi: 10.1136/heartjnl-2018-313439. [Epub ahead of print]

PMID:
30209122
40.

Development and validation of a risk prediction model in patients with adult congenital heart disease.

Baggen VJM, Venema E, Živná R, van den Bosch AE, Eindhoven JA, Witsenburg M, Cuypers JAAE, Boersma E, Lingsma H, Popelová JR, Roos-Hesselink JW.

Int J Cardiol. 2019 Feb 1;276:87-92. doi: 10.1016/j.ijcard.2018.08.059. Epub 2018 Aug 22.

PMID:
30172474
41.

Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial.

Van Mieghem NM, Unverdorben M, Valgimigli M, Mehran R, Boersma E, Baber U, Hengstenberg C, Shi M, Chen C, Saito S, Veltkamp R, Vranckx P, Dangas GD.

Am Heart J. 2018 Nov;205:63-69. doi: 10.1016/j.ahj.2018.07.006. Epub 2018 Aug 29.

PMID:
30172099
42.

IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3).

van den Berg VJ, Haskard DO, Fedorowski A, Hartley A, Kardys I, Caga-Anan M, Akkerhuis KM, Oemrawsingh RM, van Geuns RJ, de Jaegere P, van Mieghem N, Regar E, Ligthart JMR, Umans VAWM, Serruys PW, Melander O, Boersma E, Khamis RY.

EBioMedicine. 2018 Oct;36:63-72. doi: 10.1016/j.ebiom.2018.08.023. Epub 2018 Aug 18.

43.

Cardiometabolic Biomarkers and Their Temporal Patterns Predict Poor Outcome in Chronic Heart Failure (Bio-SHiFT Study).

Brankovic M, Akkerhuis KM, Mouthaan H, Brugts JJ, Manintveld OC, van Ramshorst J, Germans T, Umans V, Boersma E, Kardys I.

J Clin Endocrinol Metab. 2018 Nov 1;103(11):3954-3964. doi: 10.1210/jc.2018-01241.

PMID:
30113647
44.

Prevalence and consequences of noncardiac incidental findings on preprocedural imaging in the workup for transcatheter aortic valve implantation, renal sympathetic denervation, or MitraClip implantation.

Feyz L, El Faquir N, Lemmert ME, Misier KR, van Zandvoort LJC, Budde RPJ, Boersma E, Zijlstra F, de Jaegere P, Van Mieghem NM, Daemen J.

Am Heart J. 2018 Oct;204:83-91. doi: 10.1016/j.ahj.2018.06.015. Epub 2018 Jul 12.

45.

Addition of routinely measured blood biomarkers significantly improves GRACE risk stratification in patients with myocardial infarction.

van Toorenburg M, van den Berg VJ, van der Ploeg T, Heestermans AA, Dirksen MT, Hautvast RW, Drexhage O, Boersma E, Kardys I, Umans VAWM.

Int J Cardiol. 2018 Dec 15;273:237-242. doi: 10.1016/j.ijcard.2018.07.100. Epub 2018 Jul 21.

PMID:
30055951
46.

Adverse Events Associated With PCSK9 Inhibitors: A Real-World Experience.

Gürgöze MT, Muller-Hansma AHG, Schreuder MM, Galema-Boers AMH, Boersma E, Roeters van Lennep JE.

Clin Pharmacol Ther. 2019 Feb;105(2):496-504. doi: 10.1002/cpt.1193. Epub 2018 Sep 7.

PMID:
30053327
47.

Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.

Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Mäkikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF 3rd, Stables RH, Stone GW, Serruys PW, Kappetein AP.

J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.

PMID:
30025574
48.

SYNTAX score II predicts long-term mortality in patients with one- or two-vessel disease.

Vroegindewey MM, Schuurman AS, Oemrawsingh RM, van Geuns RJ, Kardys I, Ligthart J, Daemen J, Boersma E, Serruys PW, Akkerhuis KM.

PLoS One. 2018 Jul 2;13(7):e0200076. doi: 10.1371/journal.pone.0200076. eCollection 2018.

49.

One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention: results of the prospective rijnmond collective cardiology research study.

Yetgin T, Boersma E, Smits PC, de Vries AG, Huijskens E, Zijlstra F, van der Linden MMJM, van Geuns RJM; CCR Study Investigators.

Neth Heart J. 2018 Aug;26(7-8):393-400. doi: 10.1007/s12471-018-1126-0.

50.

Implantable cardioverter-defibrillator in Chagas heart disease: A systematic review and meta-analysis of observational studies.

Carmo AAL, de Sousa MR, Agudelo JF, Boersma E, Rocha MOC, Ribeiro ALP, Morillo CA.

Int J Cardiol. 2018 Sep 15;267:88-93. doi: 10.1016/j.ijcard.2018.05.091. Epub 2018 May 29.

PMID:
29871807

Supplemental Content

Loading ...
Support Center